Aoxing Pharmaceutical Company, Inc.
AOXG · OTC
6/30/2025 | 6/30/2024 | 6/30/2016 | 6/30/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | – | $6,912 | $5,372 |
| Short-Term Investments | – | – | $0 | $0 |
| Receivables | – | – | $11,200 | $5,854 |
| Inventory | – | – | $2,842 | $3,240 |
| Other Curr. Assets | – | – | $5,913 | $6,630 |
| Total Curr. Assets | – | – | $26,867 | $21,096 |
| Property Plant & Equip (Net) | – | – | $25,604 | $28,652 |
| Goodwill | – | – | $0 | $0 |
| Intangibles | – | – | $1,878 | $485 |
| Long-Term Investments | – | – | $4 | $96 |
| Tax Assets | – | – | $1,879 | $2,712 |
| Other NC Assets | – | – | $0 | $0 |
| Total NC Assets | – | – | $29,365 | $31,945 |
| Other Assets | – | – | $0 | $0 |
| Total Assets | – | – | $56,232 | $53,041 |
| Liabilities | – | – | – | – |
| Payables | – | – | $2,710 | $3,625 |
| Short-Term Debt | – | – | $25,472 | $30,438 |
| Tax Payable | – | – | $2,620 | $1,282 |
| Deferred Revenue | – | – | $414 | $291 |
| Other Curr. Liab. | – | – | $7,014 | $5,895 |
| Total Curr. Liab. | – | – | $37,816 | $41,240 |
| LT Debt | – | – | $0 | $1,369 |
| Deferred Rev, NC | – | – | $340 | $369 |
| Deferred Tax Liab, NC | – | – | $0 | -$0 |
| Other NC Liab. | – | – | $0 | $0 |
| Total NC Liab. | – | – | $340 | $1,738 |
| Other Liabilities | – | – | $0 | $0 |
| Cap. Leases | – | – | $0 | $0 |
| Total Liabilities | – | – | $38,156 | $42,978 |
| Equity | – | – | – | – |
| Pref Stock | – | – | $0 | $0 |
| Common Stock | – | – | $76 | $70 |
| Retained Earnings | – | – | -$56,294 | -$58,355 |
| AOCI | – | – | $1,724 | $3,066 |
| Other Equity | – | – | $73,630 | $66,457 |
| Total Equity | – | – | $19,136 | $11,238 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | – | -$1,060 | -$1,175 |
| Total Liab. & Tot. Equity | – | – | $56,232 | $53,041 |
| Net Debt | $0 | $0 | $18,560 | $26,436 |